Evome Medical Technologies Inc.
LNDZF · OTC
12/31/2023 | 2/28/2022 | 2/28/2021 | 2/29/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $8 | $7 | $8 |
| Short-Term Investments | $0 | $0 | $0 | $1 |
| Receivables | $10 | $7 | $0 | $0 |
| Inventory | $10 | $5 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $21 | $20 | $13 | $9 |
| Property Plant & Equip (Net) | $13 | $5 | $0 | $0 |
| Goodwill | $6 | $10 | $0 | $0 |
| Intangibles | $7 | $7 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $0 | $0 |
| Total NC Assets | $27 | $23 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $48 | $43 | $13 | $9 |
| Liabilities | – | – | – | – |
| Payables | $7 | $3 | $0 | $0 |
| Short-Term Debt | $18 | $6 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $1 | $0 | $0 |
| Other Curr. Liab. | $13 | $13 | $6 | $0 |
| Total Curr. Liab. | $38 | $23 | $6 | $0 |
| LT Debt | $7 | $9 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $2 | $0 | $0 |
| Other NC Liab. | $0 | -$4 | $0 | $0 |
| Total NC Liab. | $7 | $6 | $0 | $0 |
| Other Liabilities | $0 | $0 | -$0 | -$0 |
| Cap. Leases | $8 | $4 | $0 | $0 |
| Total Liabilities | $44 | $30 | $6 | $0 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $54 | $39 | $31 | $31 |
| Retained Earnings | -$65 | -$33 | -$29 | -$27 |
| AOCI | $2 | $1 | $1 | $1 |
| Other Equity | $13 | $7 | $4 | $3 |
| Total Equity | $4 | $13 | $7 | $9 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $48 | $43 | $13 | $9 |
| Net Debt | $24 | $7 | -$7 | -$8 |